Glypican 4: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
 
Line 21: Line 21:
{{Medicine-stub}}
{{Medicine-stub}}
{{No image}}
{{No image}}
__NOINDEX__

Latest revision as of 13:45, 17 March 2025

Glypican 4 (GPC4) is a member of the glypican family, which is a group of heparan sulfate proteoglycans attached to the cell surface via a glycosylphosphatidylinositol (GPI) anchor. Glypicans are involved in the regulation of cell growth and division, and they play a critical role in the modulation of signaling pathways during development and in the adult organism. GPC4, like other members of the glypican family, is implicated in the regulation of various cellular processes through its interaction with growth factors, cytokines, and other extracellular ligands.

Structure and Function[edit]

GPC4 is composed of a core protein to which several heparan sulfate glycosaminoglycan chains are covalently attached. The GPI anchor that tethers GPC4 to the cell membrane allows it to participate in a variety of signaling pathways by acting as a co-receptor for growth factors and cytokines. GPC4 is involved in the regulation of Wnt signaling, BMP signaling, and FGF signaling, among others. These pathways are crucial for proper embryonic development, including limb formation and central nervous system development.

Role in Disease[edit]

Alterations in GPC4 expression or function have been associated with several diseases. In particular, mutations or dysregulation of GPC4 has been linked to developmental disorders and cancers. For example, aberrant GPC4 expression has been observed in certain types of breast cancer and melanoma, suggesting a role in tumorigenesis. Additionally, GPC4 has been implicated in neurological conditions, such as autism spectrum disorder (ASD), where its role in neural development and synaptic function is of particular interest.

Research and Clinical Implications[edit]

Understanding the precise mechanisms by which GPC4 influences signaling pathways and cellular processes opens up potential therapeutic avenues. For instance, targeting GPC4-mediated pathways could offer new strategies for cancer treatment or for modulating developmental processes in genetic disorders. Moreover, as research into the glypican family expands, GPC4's interactions with other molecules and its effects on additional signaling pathways are likely to be elucidated, further broadening the potential for clinical applications.

See Also[edit]

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!